Market Tracker

09/22 7:58am ET

Hyperion Therapeutics Inc (NASDAQ:HPTX)

24.62
Data as of Sep 19
 -1.37 / -5.27%
Today’s Change
18.97
Today|||52-Week Range
32.98
+21.76%
Year-to-Date

Today’s Trading

Previous close25.99
Today’s open26.11
Day’s range-- - --
Volume227,590
Average volume (3 months)135,430
Market cap$507.1M
Dividend yield--
Data as of 09/19/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-32.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio27.7
Price/Sales9.30
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc+2.54+12.14%
ONVOOrganovo Holdings In...-0.42-6.01%
OSIROsiris Therapeutics ...+0.31+2.36%
CGENCompugen Ltd-0.03-0.33%
Data as of 09/19/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$42.2M
Annual profit (last year)$16.6M
Net profit margin39.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts